levels of circulating leptin and are resistant to the effects of leptin.
Because leptin therapy in obese humans with elevated leptin levels has proven to be ineffective, enthusiasm for this therapeutic strategy has been abandoned. 3 Leptin resistance is caused by either reduced/insufficient transport across the blood-brain barrier (BBB) 4 or defective leptin receptor signalling in the hypothalamus. 5 The latter more specifically is defined as cellular leptin resistance. Chronic overexpression of leptin in the CNS induces a leptin resistance comparable to diet-induced or adult-onset obesity that results in reduced leptin receptors, diminished signalling and impaired responsiveness to exogenous leptin. 6, 7 Furthermore, central leptin overexpression increases susceptibility to diet-induced obesity. 8 These findings suggest a role of elevated leptin levels in the development of leptin resistance.
Accumulating evidence points toward a sexual dimorphism in the onset of leptin resistance. 9, 10 When submitted to a high-fat diet, males tend to develop leptin resistance at an earlier stage than females. For example, after 8-week exposure to a high-fat diet, female mice remained responsive to i.p. injections of leptin, 11 whereas males were leptin resistant. 12 A sex bias in the onset of leptin resistance was also observed in mice that ectopically express agouti protein. 10 Female gonadal hormones may be the primary contributor to the sex bias in the onset of leptin resistance. Oestradiol is known to enhance leptin synthesis and to induce leptin gene expression in subcutaneous, perirenal and parametrial rat adipocytes. 13 Another potential mechanism explaining sex differences in leptin responsiveness is the relatively greater binding to the soluble form of the leptin receptor in males relative to females, which results in lower leptin transport across the BBB. 14 Although leptin is secreted principally by adipocytes, Wiesner et al 15 have identified the brain as a producer of leptin by measuring of transcerebral leptin flux. Remarkably, they found that the female brain synthesises more leptin than the male brain. Leptin produced in the brain might exert a paracrine effect in the hypothalamus, hence establishing another mechanism for sex bias in leptin sensitivity. When weight-or age-matched, females exhibit hypophagia and lose body weight at lower doses of leptin than males. 16 Interestingly, altering the hormonal environment in males by the addition of oestradiol enhances the anorexic response to central leptin injection, suggesting a role for sex steroid milieu on central leptin sensitivity. 17 The modulation of central leptin sensitivity by female gonadal hormones might be a result of oestradiol enhanceing hypothalamic expression of the long form of the leptin receptor. 18 In an attempt to further document sex-specific energy homeostasis regulation, we examined chronic leptin activation and chronic leptin receptor partial blockade 7, 19 on the long-term regulation of body weight in male and female rats. Accordingly, we employed recombinant adeno-associated virus serotype one (rAAV1)-mediated gene delivery to overexpress leptin or a mutant of rat leptin that produces a protein acting as a neutral leptin receptor antagonist and also examined the long-term sex-specific changes in feeding, body weight and body composition. We hypothesised that there would be greater weight loss following leptin gene delivery and enhanced weight gain upon partial leptin receptor blockade in females compared to males.
| MATERIALS AND METHODS

| Animals
Three-month old male and female Sprague-Dawley rats (n = 54), were obtained from Taconic (Germantown, NY, USA). Upon arrival, animals were housed individually under a 12:12 hour light/dark cycle. All rats were allowed at least 1 week to acclimatise to their new environment and daily handling before beginning any experiment. Rats were fed a standard rodent chow (18% kcal from fat, no sucrose, 3.1 kcal g
Envigo Teklad Global diet 2918; Envigo, Huntingdon, UK). Health status, body weight and food intake were monitored daily throughout the study. However, to treat all statistical analyses the same, only a few time points were reported and those time point match other body composition analyses described below. All experimental protocols were approved by the University of Florida's Animal Care and Use
Committee, and in compliance with the "Guide for the Care and Use of Laboratory Animals".
| Surgeries and group
Rats were anaesthetised with isoflurane (2%-3%) and adminis- 20 These coordinates were validated by injecting a bromothymol blue dye. The pTR(2)ObW construct encoding leptin transgene was packaged as described previously. 21 To generate the Leptin-Antagonist vector, rat DNA wild-type amino acid sequence leucine (L39), aspartic acid (D40) and phenylalanine (F41) was mutated to alanine, alanine and alanine, and aspartic acid (D23) was mutated to leucine and was pharmacologically characterised as dominant negative leptin mutant. 21 The viral vectors
Control and Leptin were packaged by the University of Florida vector core and the Leptin-Antagonist vector was packaged by Vectorbiolabs (Philadelphia, PA, USA).
| Determination of body composition using timedomain nuclear magnetic resonance
Body composition was determined at days 0, 7, 14 and 26 using time-domain nuclear magnetic resonance (TD-NMR; Minispec, Figure S1 ). Given the substantial differences in baseline values between males and females, data are presented as the percentage change from the initial values to limit data interpretation bias. For example, the formula used to calculate delta fat mass (ΔFM) was: 
| Acute central leptin administration
| Tissue collection, harvesting and preparation
After leptin delivery, rats remained anaesthetised for 1 hour on a heat pad. Then, blood was collected into syringe, transfered and centrifuged into serum separation tubes. Thereafter, 30 mL cold 0.9% saline were perfused in the circulatory system to remove blood from the brain.
The hypothalamus was dissected from the whole brain by a medial incision to the piriform lobes, caudal to the optic chiasm and anterior to the cerebral crus to a depth of 2.5 mm and immediately snap frozen in liquid nitrogen. Several other organs and tissues were removed and weighed (AE 163; Mettler-Toledo, Greifensee, Switzerland). Five fat depots were collected: mesenteric (mWAT), perirenal (pWAT), epididymal for males or parameterial for females, retroperitoneal and interscapular brown adipose tissue (iBAT). Several lean tissues were collected: gastrocnemius, soleus, plantaris, tibialis anterior and extensor digitorum longus, heart, liver, and kidneys. The hypothalamus samples were stored at −80°C until analyses were performed.
| Western analysis
The hypothalami were sonicated in 270 μL of homogenisation buffer (Tris-HCL 10 mM; pH 6.9, and 2% SDS in the presence of phosphatase/ protease inhibitors; Thermo Scientific, Rockford, IL, USA). Protein lysates were separated by sodium dodecyl sulphate-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes.
Immunoreactivity was detected with ECL prime (GE Healthcare, Piscataway, NJ, USA), scanned with a ChemiDoc XRS+ (BioRad, Hercules, CA, USA) and quantified using imagej (NIH, Bethesda, MD, USA). All values were normalised to the mean of the Control group for each sex and reported as a percentage. Phospho-STAT3 content was determined by comparing the signals obtained using antibodies specific to the phosphorylated protein (P-STAT3; Cell Signaling, Danvers, MA, USA) relative to those obtained using antibodies that bind both phosphorylated and unphosphorylated STAT3 (STAT3; Cell Signaling).
A ratio of P-STAT3 over STAT3 was generated for each animal. The signal ratio (P-STAT3/STAT3) was then normalised to the mean ratio of the control group, established at 100%.
| Serum leptin
Enzyme immunoassays were used to measure serum leptin levels (rat leptin enzyme-linked immunosorbent assay kit; EZRL-83K; Milipore,
Waltham, MA, USA). Leptin was assayed with the blood (fed state)
that was collected during euthanasia.
| Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was extracted from the hypothalamus using TRI reagent The gene expression of leptin was determined with SYBR Green Supermix using primer sets designed to specifically amplify leptin generated from the vector (forward 5′-GGCAACGTGCTGGTTATTGT-3′
and 5′-ATATCCATCACACTGGCGGC-3′). Gapdh (forward 5′-TCTC TGCTCCTCCCTGTTCT-3′ and reverse 5′-TACGGCCAAATCCGTTC ACA-3′) was used as the housekeeping gene. iq (Bio-Rad, Hercules, CA, USA) was used to detect the amplification level and programmed with an initial step of 3 minutes at 95°C, followed by forty cycles for 5 seconds at 95°C and 15 seconds at 60°C. All reactions were run in duplicate and the average of threshold cycle (C T ) was used for quantification. The relative quantification of the target genes was determined using the ΔΔC T method. Briefly, the C T values of the target genes were normalised (ΔC T = C T target − C T Gapdh ) and compared with a calibrator (ΔΔC T = ΔC T Sample − ΔC T Calibrator ). Relative expression was calculated using iq (Bio-Rad).
| Statistical analysis
Results are expressed as the mean±SE. For endpoint analyses, differences between means were tested for statistical significance (P < .05) using a one-way ANOVA and Tukey's multiple comparison tests were applied in the event of a significant effect (P < .05). For longitudinal analyses, we employed repeated measures (mixed model)
ANOVA using time and viral vectors as main factors and performed a Bonferroni post-hoc test in the case of a significant interaction between variables.
| RESULTS
| Males are less responsive to central leptin gene delivery than females and exhibit accelerated onset of leptin resistance
Leptin was overexpressed in a manner that would maximise the chance to activate leptin receptors throughout the brain. Gene transduction utilised rAAV serotype one, which readily infects the cells lining the third ventricle but is less specific for neuronal cells. This was previously confirmed by immunohistochemistry in the brain of rats injected with the Control vector (GFP). 22 The leptin construct contains a secretory sequence and thus the leptin protein is secreted into the third ventricle and potentially can reach leptin receptors throughout the brain. We have previously demonstrated that leptin gene delivered using this serotype increases the level of leptin by 75% in cerebrospinal fluid. 23 In the present study, the expression of the leptin transgene, leptin mRNA was examined in the hypothalamus by RT-PCR using a sense primer specific to a region of the vector that is not present in native rat leptin and an antisense primer specific for leptin.
This method allowed detection of leptin mRNA in Leptin but not in
Control animals ( Figure 1 ). 
Six weeks after vector delivery, GFP
| Central leptin gene delivery induced higher fat and lean mass catabolism in females
Body composition analyses indicated that both Leptin groups lost Figure S1H ). In males, lean/fat mass ratio was significantly reduced in the Leptin-Antagonist group at day 14 and 26 (Control vs Leptin-Antagonist: P < .01) ( Figure 3E ) but was preserved in Leptin-Antagonist-females.
| Central leptin gene overexpression differentially affects lean tissue weight in males and females
Consistent with TD-NMR data, Leptin groups displayed lower abdominal fat pad mass than respective Control groups (Control vs Leptin: P < .05) ( Table 1) . In attempt to identify the source of LBM differences across groups, the mass of several lean tissues was weighed. The mass of heart, kidneys, liver, tibialis anterior, gastrocnemius, plantaris, soleus and extensor digitorum longus was significantly lower in Leptin relative to Control-females (Control vs Leptin: P < .05) ( Table 1 ). In males, only liver mass was determined to be lower in the Leptin group (Control vs Leptin: P < .05) ( Table 1) . Consistent with previous studies, 23 iBAT mass was lower in Leptin than in Control rats (Control vs Leptin: P < .05) ( Table 1) . Leptin-Antagonist-males accumulated significantly more fat in all depots relative to Control-males (Control vs Leptin-Antagonist: P < .01) ( Table 1) . However, in females, only pWAT and mWAT were significantly enlarged (Control vs LeptinAntagonist: P < .05) ( Table 1 ), suggesting that females were slightly less responsive to Leptin antagonism than males. In both sexes, Leptin-Antagonist animals exhibited higher iBAT mass than Control animals (Control vs Leptin-Antagonist: P < .01) ( Table 1) .
| Despite differences in physiological responses, central leptin gene overexpression induced cellular leptin resistance in both sexes despite no change in serum leptin
Consistent with attenuated physiological responses recorded in males, leptin gene delivery was associated with lower leptin-mediated phosphorylation of STAT3, indicative of lower leptin receptor activity and onset of leptin resistance (Control vs Leptin: P < .05) ( Figure 4A ).
Unexpectedly, in contrast to their persistent physiological responses,
acute Leptin-induced P-STAT3 was also attenuated in Leptin-females, 
| DISCUSSION
Although sexual dimorphisms in the field of obesity have been clearly established more than a decade ago, 24 limited attention has been paid to sex differences in homeostatic control of body weight. Leptin resistance is considered as the main constraint to pharmacological leptin treatment for obesity, and examinations of sex differences in this process are scarce. Although female sex and hormonal milieu are clear modulators of acute leptin sensitivity, 16 ,17 their long-term roles with respect to the leptin response and the onset of leptin resistance have yet to be established. Without further understanding the sex-specific onset of leptin resistance, the development of effective therapies to combat obesity will remain challenging.
Leptin resistance is characterised as a defect in central leptin receptor-mediated signalling, 5 a feature that pharmacologically resembles submaximal central leptin receptor blockade. 19 Leptin resistance can be triggered by high and persistent leptin receptor signalling. 7 We previously demonstrated that central leptin gene delivery rapidly induces leptin resistance in high-fat fed and/or aged male rodents. 7 In addition, our laboratory has also developed a unique tool to achieve partial blockade of endogenous leptin receptor activity using virusmediated gene delivery of a leptin antagonist. 19 This approach enabled us to explore the influence of lower leptin receptor activity, a model for cellular leptin resistance, on body weight homeostasis without disturbing peripheral responses to leptin. However, our models lack an effective validation system that could determine more accurate sex On the other hand, the results from the present study do not support our initial hypothesis that females would develop more severe obesity than males in response to central leptin receptor blockade.
Unlike with Leptin vector, few sex differences were observed with Leptin-Antagonist treatment. Males and females displayed similar body weight and fat mass gain. We found that only two fat pads out of four were enlarged in Leptin-Antagonist-females, whereas LeptinAntagonist-males accumulated significantly more fat in all depots collected compared to Control counterparts. Unlike females, LeptinAntagonist-males did not display significantly higher serum leptin levels than control males. This is surprising given that serum leptin levels are positively associated with adiposity. This sex bias may simply be a result of the female hormone environment, more specifically the higher oestradiol levels in females, known to enhance leptin secretion in adipose tissues. 13 Leptin-Antagonist-females gained significantly more LBM than Control-females and such a phenomenon was not observed in respective male groups. Consequently, the lean/ fat mass ratio was lower in Leptin-Antagonist-males compared to
Control-males. These observations are puzzling considering that the partial antagonist blockade was apparently less effective in the males than females based on leptin receptor signalling, as described in detail below.
Consistent with leptin-induced cellular leptin resistance, leptin gene delivery was associated with both reduced physiological responses and lower acute leptin-mediated STAT3 phosphorylation in males. Surprisingly, the acute increase in P-STAT3/STAT3 ratio was also less pronounced in Leptin-females compared to Control-females despite persistent physiological responses. One potential explanation is that the onset of leptin resistance occurred just prior to the end of the experiment at day 26. In line with this hypothesis, Leptin-females and Control-females consumed the same amount of food on the last day of the experiment. Normalisation of food intake likely would have required several days to translate into body weight gain. Future long-term studies are necessary to evaluate whether females would eventually regain the lost weight. Another potential explanation for discord between maximal leptin receptor signalling and physiological responses is that these functions are not tightly coupled. Our previous studies utilising a leptin receptor antagonist indicated that leptin-mediated P-STAT3 signalling and metabolic responses are uncoupled. 27 Additionally, other studies found that leptin also controls metabolism via mechanisms that are independent of STAT3 phosphorylation. 28, 29 It should be noted that other signalling cascades also induce the phosphorylation of STAT3. Although P-STAT3 is not specific to leptin signalling, high affinity and specificity antibodies to assess leptin receptor activation (phospho leptin receptor) are currently not commercially available and therefore, P-STAT3 antibodies remain valuable tools for comparing leptin receptor activation across groups that underwent similar treatments.
In the present study, body weight in response to Leptin-Antagonist was similar in both sexes compared to their respective Control group;
however, there was a sexual dimorphism in leptin-mediated P-STAT3.
Treatment with the Leptin-Antagonist vector in males did not attenuate leptin-induced P-STAT3 to the same extent as in females. One speculative explanation is that there is a greater number of leptin receptors or a greater reserve capacity in the males and the level of antagonist expression was unable to sufficiently saturate the receptors. To confirm this hypothesis, future studies should compare the P-STAT3/STAT3 ratio in a dose-response to the Leptin-Antagonist vector between sexes. Again, replicating those experiment in different rat strains and in other model organisms would help to establish any stronger conclusion of a sex bias.
Collectively, these data suggest that the female hormonal milieu enhances long-term leptin responsiveness. However, it is unclear whether the nature of physiological responses is a function of high female or low male sex hormone levels. Acute injections of leptin into the third ventricle of rats inhibits eating to a greater extent in females than in males and those differential responses are likely mediated by female sex hormones because oestradiol treatment in males enhances leptin responsiveness. 16, 17 However, androgens appear to affect leptin potency in am opposite manner to oestrogens and this could potentially contribute to sex difference in leptin physiology. The androgen 5α-dihydrotestosterone reduced leptin sensitivity in ovariectomised female rats 30 and exacerbated obesity in castrated male mice. 31 Furthermore, the primary male sex hormone testosterone interacts with the negative-feedback signal of the leptin receptor SOCS3 (suppressor of cytokine signalling 3). Testosterone enhances this negative-feedback mechanism and hence could contribute to sex differences in leptin sensitivity.
Future studies aiming to evaluate the roles of male hormones with respect to long-term leptin responsiveness would be necessary to confirm this hypothesis.
In summary, the present study has established a clear sex bias in long-term central leptin responsiveness. We found differential physiological responses to central leptin gene delivery in male and female rats. Females displayed greater and more sustained physiological responses to central leptin gene delivery than males. Additionally, the lean/fat mass ratio was lower in Leptin-Antagonist-males than in
Control-males but not in the respective female groups. It is likely that the hormonal milieu contributed to sex differences; however, future studies are needed to establish whether physiological responses are mediated by female or male sex hormones.
